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Abstract 
Background and aims: Despite recent gains in the amount and quality of early autism 
intervention research, identifying what works for whom remains an ongoing challenge. 
Exploiting data from the Preschool Autism Communication Trial (PACT), we undertook 
secondary analysis to explore prognostic indicators and predictors of response to one year of 
PACT therapy vs. Treatment as Usual (TAU) within this large and rigorously characterised 
cohort recruited across three UK trial sites. Methods: In this secondary analysis of variability 
in child gains on the primary trial outcome measure – social-communication symptom 
severity – we used a pragmatic and data-driven approach to identify a subgroup of children 
who showed reliable improvement and a subgroup showing clear lack thereof. We then tested 
which among several baseline child and family factors – including measures routinely 
collected in research trials and clinical practice – varied as a function of child outcome status 
and treatment group. Results: Greater baseline child non-verbal ability was a significant 
prognostic indicator of symptom reduction over time (i.e., irrespective of treatment group). 
By contrast, parent synchrony presented as marginal predictor, and trial recruitment site as a 
significant predictor, of differential outcome by treatment group. Specifically, lower parent 
synchrony showed some association with poorer outcomes for children from families 
assigned to TAU (but with no such effect for those assigned to PACT). Similarly, children at 
one recruitment site were more likely to have poorer outcomes if assigned to TAU, compared 
to children at the same site assigned to PACT. Conclusions: The current data contribute to an 
evidence base indicting that early non-verbal ability is a robust indicator of generally better 
prognosis for young children with autism. Lower parent synchrony and a broadly more 
deprived socio-geographical context may inform the appropriate targeting of PACT. That is, 
given that the former factors predicted poorer outcome in children from families assigned to 
TAU, the receipt of a relatively low-dose, parent-mediated and communication-focused 
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therapy might be developmentally protective for young children with autism. Nevertheless, 
results from this study also highlight the paucity of meaningful predictors of outcome among 
routine clinical characterisation measures such as those investigated here. Implications: 
Understanding the factors associated with differential treatment outcomes is critical if we are 
to individualise treatment decisions for children with autism. Inherently tied to this objective 
is a need to delineate those factors which specifically predict positive response (or lack of 
response) to one or other treatment option, versus those that indicate generally better (or 
poorer) prognosis, irrespective of treatment. 
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Short Report: Predictors of reliable symptom change: Secondary analysis of the Preschool 
Autism Communication Trial 
Autism is highly heterogeneous, with core symptoms, cognitive and adaptive skills, 
and associated behaviour difficulties varying widely (Jeste & Geschwind, 2014). While 
systematic reviews and meta-analyses demonstrate the promise of various early childhood 
intervention approaches (e.g., Kasari et al., 2015; Oono et al., 2013; Smith & Iadarola, 2015), 
heterogeneity remains a major barrier to determining best-practice (Romancyzk et al., 2014; 
Spence & Thurm, 2010). Even where trials demonstrate overall efficacy, some children show 
little improvement (Magiati et al., 2012) and, conversely, some children make considerable 
gains in the absence of intervention (Howlin et al., 2009). To further the field, it is important 
that we identify those children with autism most likely to benefit from a given intervention 
approach and any for whom the approach may be contraindicated (Kraemer et al., 2002). 
Three key barriers to this end include: 1) inconsistent use of terminology and methods, in 
studies reported to date, for delineating predictors of positive response (or lack of response) 
to a particular treatment option vs. prognostic indicators of generally better (or poorer) 
outcome irrespective of treatment; 2) lack of guidelines for what constitutes meaningful 
improvement (or lack thereof) for young children with autism; and 3) limited numbers of 
adequately designed and well-powered studies to address this broad aim. 
Prognostic Indicators vs. Predictors of Response  
The extant literature highlights a variety of characteristics associated with more 
positive outcomes for young children with autism. For example, milder autism symptom 
severity and better cognitive, linguistic and social skills have been shown to be associated 
with more positive outcomes in intervention studies (see Vivanti et al., 2014) as have 
parent/family factors such as lower stress, greater motivation for and fidelity to treatment, 
higher socio-economic status (SES) and stronger support networks (e.g., Karst & van Hecke, 
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2012; Sherer & Schreibman, 2005). Further – and particularly relevant to the context of 
parent-mediated interventions – child outcomes have been associated with features of the 
parent-child relationship (Perryman et al., 2013). What remains unclear, however, is whether 
and which of these represent true predictors of positive response to intervention, as opposed 
to prognostic indicators of greater ‘natural’ improvement over time. 
Many studies inadequately separate predictors from prognostic indicators. Evidence 
of a prognostic indicator presents as a main effect (e.g., where children with characteristic X 
are observed to have better outcomes than those with characteristic Y). By contrast, evidence 
of a predictive effect presents only in a significant interaction term (e.g., where, in treatment 
condition A, children with characteristic X are observed to have better outcomes than those 
with characteristic Y, but this is not the case in treatment condition B). Hence, evaluation of 
predictors versus prognostic indicators must necessarily occur within the context of some 
comparative or controlled investigation of one treatment condition vs another. However, the 
lack of sufficient rigorously conducted, well-powered autism intervention studies means that 
we are not yet able to draw definitive and appropriate conclusions about what works for 
whom.  
Further complicating efforts toward this end, the existing evidence concerning 
associations between baseline characteristics and later outcomes for children with autism is 
also inconsistent. While milder symptoms and better cognitive/linguistic abilities tend to 
correlate with positive outcomes (e.g., Virués-Ortega, 2010), this is not true across all trials 
(e.g., Howlin et al., 2009) and these same variables often present as prognostic indicators of 
outcome in the absence of intervention (Magiati et al., 2014). Findings are similarly mixed 
regarding characteristics of parents and features of parent-child interaction behaviour (e.g., 
Perryman et al., 2013; Siller & Sigman, 2008; Vivanti et al., 2014). Further, other potentially 
relevant sources of prognostic or predictive influence – such as family ethnicity and cultural 
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values (Kasari & Patterson, 2012) and genetic and endophenotypic factors (Parr et al., 2015) 
– remain virtually unexplored in the field of autism intervention. 
What Constitutes Meaningful Improvement? 
An associated challenge for the field concerns the operationalisation of positive child 
outcomes. Rather than following best-practice guidelines to specify primary and secondary 
outcomes a-priori (e.g., National Institute for Health and Care Excellence [NICE], 2013), 
autism intervention researchers often examine multiple outcomes, including 
cognitive/linguistic skills and adaptive behaviours (Magiati et al., 2012). In the context of 
intervention for pre-schoolers with autism, a key objective is often to achieve reduction in 
core symptom presentation (Bieleninik et al., 2017). Achieving this aim has proven 
challenging (e.g., Waddington et al., 2016) and there is also little consensus on what might 
constitute meaningful reduction in core symptoms (e.g., see McConachie et al., 2015) nor on 
how to determine the appropriate target difference when planning a randomised controlled 
trial (Cook et al., 2014). Gold-standard measures to quantify autism symptom presentation 
(Lord, Risi, Lambrecht, et al., 2000; Lord, Rutter, & Le Couteur, 1994) were developed to 
inform diagnostic decision-making, rather than to sensitively measure change over time or in 
response to treatment. Nevertheless, as recently synthesised by Bieleninik et al. (2017), 
several prospective cohort studies as well as a small number of randomized controlled trials 
(e.g., Dawson et al., 2010; Green et al., 2010; Solomon et al., 2014) have adopted gold-
standard diagnostic measures as ambitious targets by which to evaluate intervention outcome. 
Background to This Study: The Preschool Autism Communication Trial 
As already described, a third key barrier to understanding how to individualise early 
autism intervention concerns the lack of studies adequately designed to address predictors of 
response. Given the proliferation of available treatment options, it is critical to determine 
whether children are more or less likely to benefit from particular approaches, and this 
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requires thorough assessment of factors associated with differential outcome (e.g., as has 
occurred elsewhere, such as for students with learning disabilities [Fuchs et al., 2012] but is 
rare in studies of autism). Beyond formal intention-to-treat (ITT), moderation and mediation 
analyses, secondary exploratory analysis of clinical trial datasets may elucidate factors 
informative for designing subsequent, hypothesis-driven trials (Kraemer et al., 2002). 
The Preschool Autism Communication Trial (Green et al., 2010) was an efficacy 
randomised controlled trial (RCT) of a parent-mediated, communication-focussed therapy 
conducted across three UK sites. Among 152 parent-child dyads, around half were assigned 
to receive Preschool Autism Communication Therapy (PACT; n=77) versus community 
treatment as usual (TAU; n=75). While Green et al. reported no significant overall ITT effect 
on the a-priori nominated primary outcome measure – severity of child social-communication 
symptoms – at 13-month treatment end-point (d= -.24; 95%CI -.59, -.11), substantial 
variability in outcomes was apparent. Nevertheless, pre-specified moderator analysis revealed 
no significant predictive effects (i.e., statistical interaction terms) among the following 
baseline measures: child age, symptom severity, non-verbal ability, receptive language, 
family SES, or trial recruitment site. 
Current Aims and Hypotheses 
We undertook secondary analysis to explore the substantial variability in child 
outcomes apparent within the PACT dataset. Using a pragmatic and data-driven approach, we 
examined which among various measures of child and parent/family factors collected at 
baseline might differentiate those children who went on to make improvement and clear lack 
of improvement in their core social-communication symptoms across the year-long trial 
period. To mirror the pragmatic context of a clinician seeking to tailor treatment to 
characteristics of the presenting client, we focused our examination on baseline measures 
commonly collected both within research trials and as part of clinical service provision – 
PREDICTORS OF CHANGE IN AUTISM SYMPTOMS     7 
 
initial child symptom severity and cognitive, linguistic and adaptive skills, and family socio-
demographic characteristics – noting that these have also previously been examined as 
potential associates of outcome within past research (e.g., Vivanti et al., 2014). As this was a 
multi-site trial and PACT was a parent-mediated intervention, we also included recruitment 
site in our investigation (see Carr et al., 2015; Nunes et al., 2010) and a measure of parent 
interaction with the child (i.e., parent synchrony; Aldred et al., 2004; Hudry et al., 2013). 
Lack of consensus in the literature precluded us from drawing strong conclusions 
around likely specific predictors of response to PACT. However, following Magiati et al. 
(2014) and Siller and Sigman (2008), we hypothesised that child cognitive/linguistic abilities 
and parent synchrony might be prognostic indicators of symptom reduction (i.e., presenting 
as main effects of child outcome). Our particular interest, however, was to understand 
whether these or other factors might predict specific response to PACT versus TAU. 
Methods 
Participants and Design 
Among the 152 dyads enrolled into PACT, 146 (96%) were retained to 13-month 
outcome (Green et al., 2010). At trial entry, children were aged 24 to 59 months, had 
≥12months non-verbal age-equivalence (NVAE; Mullen 1995) and met algorithm cut-offs for 
autism on at least two domains of the Autism Diagnostic Interview – Revised (ADI-R; Lord 
et al., 1994) as well as algorithm cut-off for autism on the Autism Diagnostic Observation 
Schedule – Generic (ADOS-G; Lord et al., 2000).  
Outcome Measure 
Our primary interest was to ascertain meaningful change on the primary trial outcome 
measure – ADOS-G social-communication algorithm score (Lord et al., 2000) – with higher 
scoring indicating greater symptom severity. As described above, the ADOS-G was 
administered at baseline as part of our procedure to confirm child diagnosis. This was re-
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administered at 13-month trial outcome, with slight adaptation to standard protocol, for the 
measure of primary outcome.  
Typically, the appropriate ADOS-G module is selected according to participant age 
and language level, and then comprises a set of relevant semi-structured tasks focusing on 
social interaction between the examiner and the participant. Module 1 is used with children 
who are minimally verbal and Module 2 with those using short phrase speech. However, as 
reported by Green et al. (2010), children in this trial were administered the same module at 
outcome assessment as had been administered at baseline, to avoid discontinuity of scores 
due to the change in module that would typically occur for a child who developed phrase 
speech. Further, slight adaptation to the conversion of raw item codes to the algorithm was 
applied, such that raw codes of 3 were retained as such (rather than rescaled to 2) and raw 
codes of 8 were rescaled to 3 (rather than to 0), thereby ensuring more sensitive measurement 
of improvement over time. 
Administration was by individuals trained to high standard and participating in regular 
coding meetings to ensure maintenance of research-level reliability. Coding of outcome 
ADOS-G assessments was conducted blind to treatment group. Intra-class correlation (ICC) 
computed from 66 ratings made across 15 tapes evidenced strong agreement among 
researchers for the standard social-communication algorithm score (ICC = 0.79) and when 
coding modifications were applied (ICC = 0.83). 
Characterisation Measures 
Additional standardized examiner-administered and parent-report assessments were 
conducted at baseline assessment, alongside the collection of parent-child interaction footage. 
As described above, for further confirmation of child diagnosis, the Autism Diagnostic 
Interview-Revised (ADI-R, Lord et al, 1994) was administered, providing a second metric of 
autism symptom severity. The ADI-R is a structured interview conducted with parents, 
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spanning the child’s full developmental history. It comprises three principal diagnostic 
domains – social interaction skills and difficulties, communication skills and difficulties, and 
restricted and repetitive behaviours – and includes cutoff scores suggestive of autism on each 
of these as well as for a symptom onset domain. 
Developmental and language abilities were assessed in several ways. The visual 
reception and fine motor scales of the examiner-administered Mullen Scales of Early 
Learning (MSEL, Mullen, 1995) were used to quantify non-verbal developmental abilities in 
the children, with a Non-Verbal Age-Equivalence (NVAE) score computed as the average of 
these domains. The parent-report MacArthur-Bates Communicative Development 
Inventories, Words and Gestures form (MCDI, Fenson et al., 1993) was administered to 
obtain raw counts of child receptive vocabulary knowledge. An expressive vocabulary count 
was also available from the MCDI, and Auditory Comprehension and Expressive Language 
standard scores were obtained from administration of the Preschool Language Scales – 3rd 
Edition, UK Adaptation (Zimmerman, Steiner & Pond, 1997). However, these were omitted 
from the main analysis due to observed multi-collinearity with MSEL NVAE and MCDI 
receptive vocabulary. 
Parent-Child Interaction. Child pragmatic communication toward the parent, and 
also parent interaction behaviour toward the child, was quantified from filmed 8-minute free-
play interaction samples via the Dyadic Communication Measure for Autism (DCMA) coding 
scheme (see Aldred et al., 2004; Green et al., 2010; Hudry et al., 2013). Specifically, coding 
of child communication focused on classifying initiations (i.e., spontaneous communication 
acts directed toward the parent) and responses (i.e., acts following on from a previous 
parental contribution). Coding of parent behaviour focused on classifying communication acts 
as synchronous (i.e., supportive of the child’s attentional focus and commenting on the 
child’s play/activity) or asynchronous (i.e., directive/redirective or placing some demand on 
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the child’s attention or behavior). For analysis, proportionate Child Initiation was computed 
as the proportion of all child communication acts that were initiations, and proportionate 
Parent Synchrony was computed as the proportion of all parent communication acts that were 
synchronous. Moderate to good inter-rater agreement was evident across these scales 
(computed from 66 ratings made across 22 tapes): Child Initiation ICC = .59; Parent 
Synchrony, ICC = .80. 
Family and treatment-related factors. Demographic data were collected via semi-
structured parent interview and questionnaire responses, and the following were dichotomous 
variables were coded for analysis: family composition (dual vs. single parent status), ethnicity 
(both parents white vs. one/both parents non-white), household Income (less than vs. equal to 
or greater than £40,000 per annum), and parental educational attainment (less than vs. equal 
to or greater than one parent with some qualification post 16-years of age). As already 
described, families were recruited from three trial sites, situated in South London, Manchester 
and the North East of England. Among families assigned to the PACT arm, the number of 
treatment sessions attended by families was also recorded for a measure of PACT dose. 
Analysis Plan 
We sought to delineate subgroups of children who improved/did not improve on their 
ADOS-G scores. While a 4-point reduction has been suggested to represent clinically 
meaningful improvement (Aldred et al., 2004), this was based on data from a relatively small 
sample. Hence, we adopted Jacobson and Truax’s (1991) Reliable Change Index (RCI), 
enabling identification of children whose improvement/deterioration could be considered 
psychometrically reliable (vs. attributable to variability of scores/measurement error; see also 
Eldevik et al., 2010). 
Following Jacobson and Truax (1991; formula below), we computed RCI z-scores for 
the change in ADOS-G from baseline to outcome. Our index of reliability (r) was the 
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correlation between baseline and outcome ADOS-G scores among children randomised to 
TAU (n=72; test-retest r=.735) and our index of variance was the standard deviation (SD) of 
ADOS-G scores at baseline (n=152; SD=4.135): 
 
RCI 𝑧 score =
(𝐴𝐷𝑂𝑆 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑠𝑐𝑜𝑟𝑒 − 𝐴𝐷𝑂𝑆 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 𝑠𝑐𝑜𝑟𝑒)
√2 (𝑆𝐷 √(1 − 𝑟) )2 
 
 
We then sought to delineate two child subgroups – reliable Improvers and Non-Improvers – 
where reliable improvement was defined by RCI z-scores < -1.96 and reliable deterioration by 
RCI z-scores >1.96 (i.e., both signifying change unlikely to have occurred by chance; p<.05). 
We then planned to conduct two-way between-subjects ANOVAs – 2 outcome status 
(Improvers, Non-Improvers) x 2 treatment group (PACT, TAU) – on continuous baseline 
characteristics of interest, or χ2 contingency analyses in the case of categorical measures. 
Again, preliminary analysis indicated multi-collinearity among many measures of 
development and language ability/knowledge taken with child participants. Hence, key 
baseline characteristics retained for these analyses were: 
• Parent-reported child autism symptoms: sum of ADI-R algorithm items, 
• Assessment of child developmental level: NVAE from MSEL, with log-10 
transformation was applied to address significant positive skew in the raw data, 
• Parent-reported receptive vocabulary count from the MCDI, 
• Proportionate Child Initiation and Parent Synchrony coded from parent-child 
interaction, with square-root transformation applied to address significant positive 
skew in raw data for the former, 
• Parent-reported demographic characteristics: family composition, ethnicity, household 
income, and highest level of education, and 
PREDICTORS OF CHANGE IN AUTISM SYMPTOMS     12 
 
• Trial recruitment site and, where relevant, dose of PACT therapy received. 
From these analyses, prognostic indicators would be evidenced by significant main effects of 
outcome status, and predictors of treatment response would be evidenced by significant two-
way (treatment group by outcome status) interaction terms. Subsequently we planned to 
include significant baseline characteristics within a logistic regression to identify which 
singly/together contributed predictive value for child Improver vs. Non-Improver outcome 
status. 
Results 
Reliable symptom improvement (i.e., RCI z <-1.96) was identified for 43 children, 
with this threshold corresponding to a ≥6-point decrease in ADOS-G scores. No child showed 
reliable deterioration in autism symptoms (i.e., RCI z >1.96), so we made the post-hoc 
decision to classify as Non-Improvers those children who made no change or showed any 
increase in ADOS-G scores over time. Hence, Non-Improvers comprised those 41 children 
whose RCI z ≥0, reflecting 0-5-point increase in ADOS-G scores. 
Table 1 shows baseline data for the whole cohort, and for Improver and Non Improver 
subgroups. We also show data for the remaining 62 children who showed intermediate, non-
reliable change (i.e., RCI z= -1.96-0), but were then excluded from further analysis. 
[table 1 about here] 
Full data supporting the principal analyses reported below are shown in the 
Supplementary Materials (Appendix A). Table 2 shows ANOVA results for the continuous 
baseline characterisation measures. A significant main effect of outcome status presented for 
baseline NVAE, such that this was greater among children who were Improvers (M=29.5, 
SD=10.6) vs. Non-Improvers (M=25.5, SD=10.8), with moderate effect size (d=.46). The 
two-way interaction term approached significance for parent synchrony, such that this was 
somewhat lower among parents from families assigned to TAU where children were Non-
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Improvers (M=23.9, SD=9.2), compared to both those families assigned to TAU where 
children were Improvers (M=30.5, SD=10.2) and to those assigned to PACT, irrespective of 
child outcome status (Improvers M=28.3, SD=11.4; Non-Improvers M=31.3, SD=16.4). 
[table 2 about here] 
Table 3 shows χ2 contingency test results for the categorical baseline characterisation 
measures. A significant association presented for trial recruitment site such that, among 
children from South London, there were more Non-Improvers than Improvers. Children 
recruited from Manchester and North-East England, however, were more often Improvers 
than Non-Improvers. Follow-up analysis indicated this association to apply only within the 
TAU trial arm such that, among families assigned to TAU, there were more Non-Improvers 
than Improvers at the South London site (vs. similar proportion of Improvers/Non-Improvers 
in TAU at the other two sites). Finally, among families assigned to PACT, therapy dose did 
not differentiate Improvers from Non-Improvers, z=.45 p=.650.  
[table 3 about here] 
We included child NVAE and interaction terms of treatment group by each of 
recruitment site and parent synchrony within a logistic regression on Improver vs. Non-
Improver outcome status. The overall model was statistically significant – χ2(3)=13.63, 
p=.009; Cox & Snell R2=.151; Nagelkerke R2=.202 – increasing correct classification from 
50.6% (no predictors entered) to 66.3%. However, only the treatment group x recruitment site 
interaction (i.e., South London vs. others) carried unique predictive value (Wald=5.28, 
p=.022), with non-significant unique effects for NVAE (Wald=2.64, p=.104) and treatment 
group x parent synchrony (Wald=0.19, p=.663). 
Given the unique association of recruitment from the South London site with poorer 
child outcomes – particularly for families not assigned to the PACT trial arm – we conducted 
further post-hoc exploration of cross-site differences in attempt to identify possible 
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explanations for this effect at this particular site. As shown in table 4, and consistent with the 
ANOVA results described above, families recruited from this site had parents with lower 
synchrony and children with lower verbal and non-verbal abilities and greater autism 
symptom severity. Families from this site were also more often single-parent and in the lower 
household income band than those at both other sites, and had somewhat lower educational 
attainment than families from North-East England. 
[table 4 about here] 
Furthermore, examination of data on families’ access to TAU services revealed that 
families recruited from South London vs. from Manchester and North East England had 
additional contacts with health, social and other therapeutic supports across the trial period. 
These included, on average, two more contacts with health service providers (including 
outpatient hospital visits or inpatient/emergency admissions, appointments with general 
practitioners, nurses, health visitors, paediatricians, dentists, ophthalmologists, audiologists, 
dieticians/nutritionists), five more contacts with providers of therapy services (including 
portage workers, educational/clinical psychologists, occupational therapists, physiotherapists, 
speech language therapists), and three more contacts with social care services (including 
social workers, family support workers, community autism specialists, home care workers, 
play workers, or visits to walk-in centres). As shown in table 5, however, none of these 
between-group differences was statistically significant and so differential access to TAU 
services is unlikely to explain the observed site-specific effects on child outcome. 
[table 5 about here] 
Discussion 
Recent reviews highlight the need for treatment to be better adapted to individual 
children with autism, particularly in light of limited resources (e.g., Romancyzk et al., 2014). 
However, identifying factors associated with differential outcomes presents a significant 
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challenge, and existing studies have often failed to differentiate true predictors of treatment 
response from indicators of generally better prognosis. Exploiting the large PACT dataset 
(Green et al., 2010), and retaining focus on the a-priori nominated primary outcome measure 
of change in core symptom severity – for which substantial variability was observed – we 
adopted a pragmatic and data-driven approach to try to identify for whom this particular 
parent-mediated, communication-focussed treatment might have been most appropriate. We 
identified subgroups of children who were reliable improvers and non-improvers in autism 
symptom severity, and then examined whether commonly available baseline characteristics 
varied between these subgroups, seeking to mirror the process that might be adopted by 
community professionals to guide individualised treatment decision-making for pre-schoolers 
with autism. 
Non-Verbal Developmental Level as a Prognostic Indicator 
Among the large cohort, followed over around one year, ~30% of children showed 
decreases in their social-communication symptoms of autism to an extent that was highly 
unlikely to have occurred by chance (and corresponding to a ≥6-point reduction on the 
ADOS-G modified algorithm total score). Similarly, a subgroup of ~28% of children showed 
a clear lack of improvement or some worsening in their symptoms across the same period. 
Nevertheless, among the various baseline factors available for our analysis – child age, initial 
autism symptom severity, receptive language knowledge, social initiations; and parent/family 
socio-demographic factors – we found a striking lack of differences between our improver 
and non-improver subgroups. 
One clear exception to this pattern of results was for child non-verbal ability, which 
presented as a significant prognostic indicator of outcome for children in this trial. This 
replicates findings from other studies (see Magiati et al., 2014) such that children who made 
reliable improvement in their autism symptoms had shown greater initial non-verbal ability 
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than those whose symptoms did not improve. That this effect was prognostic – applicable to 
children who received the PACT intervention or community TAU – rather than predictive of 
response within one particular condition or other, was identifiable within this dataset given 
sound experimental design with random assignment of children to intervention arms. 
Conversely, many studies of early autism intervention are prospective cohort studies, rather 
than intervention trials (see Bieleninik et al., 2017) within which it is not possible to 
disentangle prognostic indicators – such as non-verbal ability – from true predictors of 
treatment response. 
The Significance of Parental Communicative Synchrony 
 Alongside our clear prognostic effect of non-verbal age-equivalence, we also observed 
a trend toward significant predictive effect for parent communicative synchrony. That is, a 
marginal interaction of outcome status by treatment group presented, such that baseline parent 
synchrony was somewhat lower specifically among TAU families with children who were 
non-improvers, compared to both TAU families with children who were improvers and also 
to families assigned to PACT therapy irrespective of child outcome. This effect should be 
interpreted with caution, pending future replication work. However, we have recently 
demonstrated the mechanistic importance of parent synchrony, through mediation analysis on 
the PACT dataset, for 1) proximal gains in child initiation skills and 2) more distal reduction 
in child symptoms. That is, to the extent that participation in PACT had an overall (small, 
non-significant) effect on child symptoms (Green et al., 2010), this was achieved through a 
large proximal treatment effect on parent synchrony which brought moderate downstream 
improvements in child communicative initiations, and (attenuated) reductions in core 
symptom presentation (Pickles et al., 2015). The current result – a marginally significant 
predictive effect of reduced parent synchrony for poorer child outcomes, in the context of one 
year of receipt of community TAU – provides further support for the importance of parent 
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interaction behaviour in the context of early childhood autism. In the absence of participation 
in a therapy that focuses on supporting parent sensitive interaction with their child, greater 
‘natural’ parent synchrony may be a protective factor against (and lower ‘natural’ synchrony 
a risk factor for) poorer child outcome during the preschool period. That is, for parents with 
more limited communicative synchrony, participation in PACT therapy may mitigate the 
odds of the child maintaining or increasing their core social-communication symptoms. 
The Significance of Trial Recruitment Site  
Finally, we observed a significant predictive effect of trial recruitment site, such that 
children recruited from South London showed poor outcomes if assigned to TAU, but more 
balanced odds of core symptom improvement if assigned to receive PACT therapy. We had 
included trial site within our analysis, because of its potential impact on factors such as 
treatment session attendance and adherence to therapy processes (e.g., see Carr et al. 2015). 
When entered into the logistic regression on child outcome status, recruitment site 
carried unique predictive value in this dataset, with no further variance explained by child 
non-verbal ability or parent synchrony. Exploratory post-hoc analysis of community services 
accessed by families across the three trial sites provided no evidence that this effect might be 
underpinned by the amount or type of TAU available to families in South London vs. 
Manchester and North East England. However, this former cohort differed from those at the 
latter two sites in having higher representation of a) children with greater baseline autism 
symptoms, b) poorer verbal and non-verbal skills, c) parents with lower communicative 
synchrony, and d) more single-parent and culturally/ethnically diverse households. As noted 
by Kasari and Patterson (2012) research with under-represented populations is very limited in 
the field of autism, with few trials involving ethnically or culturally diverse samples. The 
current findings suggest that the provision of routine TAU may be inadequate, particularly for 
more disadvantaged families, even within relatively high resource countries. 
PREDICTORS OF CHANGE IN AUTISM SYMPTOMS     18 
 
Considerations and Future Directions 
Within the PACT cohort, we were able to identify a subgroup of children who showed 
clear improvement in their autism symptoms, using Jacobson and Truax’s (1991) RCI. We 
did not, however, identify any children who experienced reliable symptom deterioration. 
While this is clinically encouraging, evidence from adult mental health studies indicates that 
the predictors of positive outcomes may differ from those associated with negative treatment 
response (Starcevic & Brakoulias, 2008). Thus, further work is required to understand not 
only for whom particular interventions may be helpful but also whether there are any children 
for whom an approach may be contra-indicated. 
This field also lacks good, functional indicators of outcome for young children with 
autism. Nevertheless, evaluation of the natural developmental growth suggests the possibility 
of divergent trajectories for core symptom presentation vs. adaptive behaviour, thereby 
justifying ongoing focus on differential types of intervention outcome (Szatmari et al., 2015). 
Here, retaining the a-priori aim of the PACT trial (Green et al., 2010; Pickles et al., 2015), our 
analysis focus was on changes in child core autism symptoms. However, other constructs may 
be equally important indicators of outcome and other measures may be more sensitive to 
change over time (e.g., social-communication skills, adaptive behaviour, quality of life; 
McConachie et al., 2015). Future consideration is therefore warranted regarding the 
predictors of change in secondary outcome measures within this RCT dataset, including 
parent synchrony as the direct proximal target of PACT therapy sessions, and child initiation 
as the proximal target outcome for children. 
Statistical power for the current analysis may have been limited. However, we 
adopted this pragmatic alternative to formal moderation analysis to explore the predictors of 
clearly (i.e., reliably) positive child outcome, or clear lack thereof. Moreover, we verified that 
our observed associations of symptom change with non-verbal age-equivalence, parent 
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synchrony and site also held when more conventional analysis was undertaken retaining both 
the full participant sample and symptom change as a continuous metric. Furthermore, our 
failure to identify additional prognostic or predictive associations is unlikely to be due to 
limited statistical power as the effect sizes observed here for non-significant between-group 
comparisons were small. Rather, it seems likely that broad characterisation measures – such 
as age, core symptom severity, and developmental/cognitive ability – are insufficiently 
sensitive to serve as predictors of treatment response in young children with autism. Indeed, 
other groups have begun to explore more specific indicators of early skills – such as the 
exploration and functional use of objects, joint attention, imitation, and social motivation and 
response to social reward – as potential predictors of treatment response (see Vivanti et al., 
2014). 
Summary and Conclusion 
In summary, this study contributes to a growing empirical evidence base for the 
prognostic value of child non-verbal ability – contextualising this clearly as a prognostic 
indicator of child outcome irrespective of therapy group assignment. Further, these data 
provide some further indication of the potential importance of parent synchrony as a 
protective factor in autism (see also Pickles et al., 2015). Finally, these results highlight the 
importance of considering trial recruitment site and what comprises TAU when interpreting 
outcomes from intervention trials. These findings require replication in the context of other 
evaluations of autism treatment efficacy – including other parent-mediated approaches and 
therapist-delivered interventions alike. Our approach should equally be applied within 
community-based evaluations of treatment effectiveness. 
Tasked with identifying and providing treatment approaches best suited to particular 
children and families, clinicians face the potential misuse of costly or limited resources, and 
possible exacerbation of child behaviour problems and parent stress from wasted time and 
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effort (March, 2009; Winburn et al., 2014). Hence, it is critical to expand our understanding 
of what works for whom to develop an evidence base around individualising treatment plans 
for young children and their parents. 
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Table 1. Baseline characteristics of total cohort, and subgroups of reliable Improvers, Non-
Improvers and children making intermediate gains. 
 Cohort 
(N = 146) 
Improvers 
(N = 43) 
Intermediate 
(N = 62) 
Non-Improvers 
(N = 41) 
Child Characteristics 
Age (months) 44.7   (7.9) 45.0   (7.7) 44.7   (8.0) 44.7   (8.2) 
ADI-R algorithm score  34.3   (6.7) 34.0   (6.9) 34.8   (6.6) 33.8   (6.8) 
MSEL Non-Verbal age-equiv.1 26.3 (10.0) 29.5 (10.6) 24.6   (8.5) 25.5 (10.8) 
MCDI Receptive Vocabulary2 162   (120) 178   (110) 144   (125) 172   (122) 
Parent-Child Interaction Measures 
DCMA Child Initiation 13.7   (9.8) 14.9   (8.7) 12.2   (9.8) 14.8  (10.6) 
DCMA Parent Synchrony 28.4 (11.9) 29.2 (10.9) 28.6 (11.7) 27.3  (13.4) 
Family Measures 
Single (vs Dual) Parent Family 23% 16% 21% 32% 
Both Parents White (vs Other) 58% 67% 55% 54% 
Income <£40K (vs ≥£40K) 65% 65% 63% 68% 
Parental Education (≥1 post 16yr) 73% 74% 71% 76% 
Site1:   South London N = 50 N =   9 N = 21 N = 20 
Manchester N = 50 N = 18 N = 21 N = 11 
North East England N = 46 N = 16 N = 20 N = 10 
ADI-R: Autism Diagnostic Interview – Revised (Lord et al., 1994) 
MSEL: Mullen Scales of Early Learning (Mullen, 1995) 
MCDI: MacArthur Bates Communicative Development Inventories (Fenson et al., 1993) 
DCMA: Dyadic Communication Measure for Autism (Aldred et al., 2004; Hudry et al., 2013) 
Note. Data are mean (standard deviation) unless otherwise indicated. Descriptive statistics 
based on scores prior to log-10/square-root transformation. 1 Underline script indicates 
significant between-group differences. 2 Data missing on 5 cases.  
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Table 2. Results of ANOVAs comparing continuous baseline characteristics across Improver and Non-Improver subgroups randomised to PACT 
and TAU. 
 Main Effects  
Two-Way Interaction Outcome Status Treatment Group 
Chronological Age F(1,80) =   .08, p = .783, d = .04 F(1,80) =   .13, p = .723, d = .07 F(1,80) =   .48, p = .492, 2 = .01 
ADI-R Autism Symptoms F(1,80) =   .17, p = .685, d = .04 F(1,80) = 1.54, p = .218, d = .27 F(1,80) = 1.05, p = .310, 2 = .01 
MSEL Non-Verbal Ability F(1,80) = 4.08, p = .047, d = .46 F(1,80) =   .06, p = .806, d = .11 F(1,80) =   .10, p = .757, 2 = .00 
MCDI Receptive Vocabulary F(1,78) =   .08, p = .774, d = .05 F(1,78) =   .55, p = .462, d = .16 F(1,78) =   .19, p = .667, 2 = .00 
DCMA Child Initiation F(1,79) =   .29, p = .591, d = .13 F(1,79) =   .87, p = .353, d = .22 F(1,79) = 2.07, p = .154, 2 = .03 
DCMA Parent Synchrony F(1,79) =   .45, p = .506, d = .15 F(1,79) =   .93, p = .337, d = .23 F(1,79) = 3.28, p = .074, 2 = .04 
ADI-R: Autism Diagnostic Interview – Revised (Lord et al., 1994) 
MCDI: MacArthur Bates Communicative Development Inventories (Fenson et al., 1993) 
DCMA: Dyadic Communication Measure for Autism (Aldred et al., 2004; Hudry et al., 2013) 
MSEL: Mullen Scales of Early Learning (Mullen, 1995)  
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Table 3. Results of chi-square contingency analyses comparing categorical baseline characteristics across Improver and Non-Improver 
subgroups randomised to PACT and TAU. 
 Overall Contingency Within PACT Group Within TAU Group 
Family Composition: Single vs Dual Parent χ2(1) = 2.75, p = .097 χ2(1) =   .82, p = .365 χ2(1) = 1.66, p = .198 
Ethnicity: Both Parents White vs Other χ2(1) = 1.67, p = .196 χ2(1) = 1.46, p = .227 χ2(1) =   .55, p = .458 
Household Income: <£40K (vs ≥£40K) χ2(1) =   .10, p = .758 χ2(1) =   .89, p = .345 χ2(1) = 1.46, p = .226 
Parental Education: <1≥ parent post 16yr χ2(1) =   .02, p = .900 χ2(1) =   .63, p = .426 χ2(1) =   .01, p = .945 
Recruitment Site χ2(1) = 7.20, p = .027 χ2(1) = 1.84, p = .398 χ2(1) = 8.57, p = .014 
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Table 4. Baseline characterisation differences between families recruited into TAU trial arm at three sites. 
 South London 
(N = 26) 
Manchester 
(N = 24) 
North East England 
(N = 22) 
Difference Between South 
London and Other Two Sites 
Child Characteristics 
Age (months) 42.8   (8.2) 45.4   (8.5) 47.4    (7.4) t(70) =   1.83, p = .072; d = .40 
ADI-R algorithm score  35.9   (7.0) 35.0   (7.6) 33.4    (5.4) t(70) =     .97, p = .336; d = .21 
MSEL Non-Verbal age-equivalence (months) 22.2   (7.6) 25.6   (8.3)  29.1   (12.1) t(70) =   2.20, p = .022; d = .59 
MCDI Receptive Vocabulary 136    (122) 162   (110) 199   (141) t(67) =   1.41, p = .163; d = .35 
Parent-Child Interaction Measures     
DCMA Child Initiation 11.3   (8.5) 15.4 (10.0) 15.2 (11.3) t(70) =   1.37, p = .176; d = .30 
DCMA Parent Synchrony 23.9 (11.3) 28.3 (11.7) 30.7 (10.1) t(70) =   2.06, p = .044; d = .49 
Family Measures     
Single (vs Dual) Parent Family 39% 21% 14% χ2(1) =   3.93, p = .047 
Both Parents White (vs Other) 15% 75% 82% χ2(1) = 26.60, p < .001 
Household Income <£40K (vs ≥£40K) 85% 75% 64% χ2(1) =   2.01, p = .157 
Parental Education (≥1 post 16yr) 54% 54% 77% χ2(1) =     .90, p = .342 
ADI-R: Autism Diagnostic Interview – Revised (Lord et al., 1994) 
MSEL: Mullen Scales of Early Learning (Mullen, 1995) 
MCDI: MacArthur Bates Communicative Development Inventories (Fenson et al., 1993) 
DCMA: Dyadic Communication Measure for Autism (Aldred et al., 2004; Hudry et al., 2013) 
Note. Data are mean (standard deviation) unless otherwise indicated. Underline script indicates significant between-group differences. 
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Table 5. Numbers of contacts with services by families assigned to the TAU arm at the South London vs two other trial recruitment sites.  
 South London Manchester/North East England Coefficient 95% CI p 
N 26 43    
Health contacts 7.31   (5.56) 9.26   (6.65) -1.95   (-5.05 to 1.16) 0.215 
Therapy contacts 13.78 (13.43) 19.39 (18.26) -5.61 (-14.31 to 3.09) 0.202 
Social care contacts 6.69 (15.60) 3.21   (8.39)   3.48   (-2.28 to 9.24) 0.232 
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Supplementary Material 
 Appendix A. Detailed Participant Characterisation 
 Full descriptive statistics and the results of pair-wise comparisons between Improver and Non-Improver subgroups are shown, for all 
baseline characterisation measures, for PACT trial participants randomised to the PACT arm (table A1) and TAU (table A2). 
 
Table A1. Descriptive statistics for participants randomised to the PACT arm, and between-group comparison for Improver and Non-Improver 
subgroups within this trial arm. 
 PACT Group 
(n = 74) 
Improvers 
(n = 26) 
Non-Improvers 
(n = 19) 
Difference Between Improvers 
and Non-Improvers 
Child Characteristics     
Age (months) 44.5   (7.7) 44.3   (7.3) 45.0  (8.3) t(43) =   .31, p = .76, d = .09 
ADI-R algorithm score  33.7   (6.6) 32.7   (6.2) 33.6  (7.5) t(43) =   .45, p = .65, d = .10 
MSEL Non-Verbal age-equivalence (months) 27.1 (10.2) 29.7 (11.8) 25.9  (9.9) t(43) = 1.24, p = .22, d = .35 
MCDI Receptive Vocabulary 160    (116) 174    (106) 156   (110) t(43) =   .58, p = .57, d = .17 
Parent-Child Interaction Measures     
DCMA Child Initiation 13.6   (9.6) 14.1   (7.9) 17.7 (10.8) t(42) =   .70, p = .49, d = .38 
DCMA Parent Synchrony 29.3 (12.5) 28.3 (11.4) 31.3 (16.4) t(42) =   .73, p = .47, d = .21 
Family Measures     
Single (vs Dual) Parent Family 20% 15% 26% χ2(1) =   .82, p = .37 
Both Parents White (vs Other) 61% 65% 47% χ2(1) = 1.46, p = .23 
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Household Income <£40K (vs ≥£40K) 55% 62% 47% χ2(1) =   .89, p = .35 
Parental Education (≥1 post 16yr) 85% 81% 90% χ2(1) =   .63, p = .43 
Site:  South London 
         Manchester 
         North East England 
N = 24 
N = 26 
N = 24 
N = 7 
N = 9 
N = 10 
N = 8 
N  = 7 
N = 4 
 
χ2(2) = 1.84, p = .40 
Dose: Number of Sessions (Median, IQR) 16 (11-17) 16 (11.5-17) 16.5 (13.75-17)  z = .45, p = .65 
ADI-R: Autism Diagnostic Interview – Revised (Lord et al., 1994) 
MSEL: Mullen Scales of Early Learning (Mullen, 1995) 
MCDI: MacArthur Bates Communicative Development Inventories (Fenson et al., 1993) 
DCMA: Dyadic Communication Measure for Autism (Aldred et al., 2004; Hudry et al., 2013) 
Note. Details of whole PACT group provided for information; data for “intermediate” subgroup not included in the table. Data are mean 
(standard deviation) unless otherwise indicated.
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Table A2. Descriptive statistics for participants randomised to the TAU arm, and between-group comparison for Improver and Non-Improver 
subgroups within this trial arm. 
 TAU Group 
(n = 72) 
Improvers 
(n = 17) 
Non-Improvers 
(n = 22) 
Difference Between Improvers 
and Non-Improvers 
Child Characteristics     
Age (months) 45.1   (8.1) 46.1  (8.4) 44.4   (8.2) t(37) =   .64, p = .53, d = .20 
ADI-R algorithm score  34.8   (6.8) 36.1  (7.5) 33.9   (6.3) t(37) =   .97, p = .34, d = .32 
MSEL Non-Verbal age-equivalence (months) 25.4   (9.7) 29.1  (8.8) 25.2 (11.8) t(37) = 1.61, p = .12, d = .37 
MCDI Receptive Vocabulary 164   (125) 183  (119) 187   (133) t(35) =   .09, p = .93, d = .03 
Parent-Child Interaction Measures     
DCMA Child Initiation 13.9   (9.9) 16.2 (10.0) 12.3 (10.1) t(37) = 1.27, p = .21, d = .39 
DCMA Parent Synchrony 27.4 (11.3) 30.5 (10.2) 23.9   (9.2) t(37) = 2.13, p = .04, d = .68 
Family Measures     
Single (vs Dual) Parent Family 25% 18% 36% χ2(1) = 1.66, p = .19 
Both Parents White (vs Other) 56% 71% 59% χ2(1) =   .55, p = .46 
Household Income <£40K (vs ≥£40K) 75% 71% 86% χ2(1) = 1.46, p = .23 
Parental Education (≥1 post 16yr) 61% 65% 64% χ2(1) =   .01, p = .95 
Site:  South London 
         Manchester 
         North East England 
N = 26 
N = 24 
N = 22 
N = 2 
N = 9 
N = 6 
N = 12 
N = 4 
N = 6 
 
χ2(2) = 8.57, p = .01 
ADI-R: Autism Diagnostic Interview – Revised (Lord et al., 1994) 
MSEL: Mullen Scales of Early Learning (Mullen, 1995) 
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MCDI: MacArthur Bates Communicative Development Inventories (Fenson et al., 1993) 
DCMA: Dyadic Communication Measure for Autism (Aldred et al., 2004; Hudry et al., 2013) 
Note. Details of whole TAU group provided for information; data for “intermediate” subgroup not included in the table. Data are mean (standard 
deviation) unless otherwise indicated. Underline script indicates significant between-group difference
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